Basic fibroblast growth factor induces cholangiocarcinoma cell migration via activation of the MEK1/2 pathway

Oncology Letters

Volumn 2, Issue 5, 2011, Pages 821-825

  Narong, Siriluck ^a   Leelawat, Kawin ^a  

^a RANGSIT UNIVERSITY   (Thailand)

Author keywords

Basic fibroblast growth factor; Cell migration; Cholangiocarcinoma

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ACTIN; BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2;

ACTIN POLYMERIZATION; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CARCINOMA CELL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 79960293291     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.333     Document Type: Article

References (21)

1. Sripa B and Pairojkul C: Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol 24: 349-356, 2008.
2. Blechacz BRA and Gores GJ: Cholangiocarcinoma. Clin Liver Dis 12: 131-150, 2008.
3. Fontijn D, Bosch LJ, Duyndam MC, van Berkel MP, Janmaat ML and Boven E: Basic fibroblast growth factor-mediated overexpression of vascular endothelial growth factor in 1F6 human melanoma cells is regulated by activation of PI-3K and p38 MAPK. Cell Oncol 31: 179-190, 2009.
4. Zhang W, Chu YQ, Ye ZY, Zhao ZS and Tao HQ: Expression of hepatocyte growth factor and basic fibroblast growth factor as prognostic indicators in gastric cancer. Anat Rec (Hoboken) 292: 1114-1121, 2009.
5. Massabeau C, Rouquette I, Lauwers-Cances V, et al: Basic fibroblast growth factor-2/beta3 integrin expression profile: signature of local progression after chemoradiotherapy for patients with locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 75: 696-702, 2009.
6. Dai H, Zhao S, Xu L, Chen A and Dai S: Expression of Efp, VEGF and bFGF in normal, hyperplastic and malignant endometrial tissue. Oncol Rep 23: 795-799, 2010.
7. Su WC, Shiesh SC, Liu HS, Chen CY, Chow NH and Lin XZ: Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders. Dig Dis Sci 46: 1387-1392, 2001.
8. Rattanasinganchan P, Leelawat K, Treepongkaruna SA, et al: Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient. World J Gastroenterol 12: 6500-6506, 2006.
9. Sripa B, Leungwattanawanit S, Nitta T, et al: Establishment and characterization of an opisthorchiasis-associated cholangio-carcinoma cell line (KKU-100). World J Gastroenterol 11: 3392-3397, 2005.
10. Turner N and Grose R: Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 10: 116-129, 2010.
11. Pardo OE, Latigo J, Jeffery RE, et al: The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo. Cancer Res 69: 8645-8651, 2009.
12. Nomura S, Yoshitomi H, Takano S, et al: FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer. Br J Cancer 99: 305-313, 2008.
13. McMahon A, Reeves GT, Supatto W and Stathopoulos A: Mesoderm migration in Drosophila is a multi-step process requiring FGF signaling and integrin activity. Development 137: 2167-2175, 2010.
14. Ozkan S, Vural B, Dalcik C, Tas A and Dalcik H: Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic and neural cell adhesion molecule in pregnancies with small for gestational age fetuses. J Perinatol 28: 468-474, 2008.
15. Korc M and Friesel RE: The role of fibroblast growth factors in tumor growth. Curr Cancer Drug Targets 9: 639-651, 2009.
16. Sato T, Oshima T, Yoshihara K, et al: Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer. Oncol Rep 21: 211-216, 2009.
17. Vignjevic D and Montagnac G: Reorganisation of the dendritic actin network during cancer cell migration and invasion. Semin Cancer Biol 18: 12-22, 2008.
18. Abe M, Inoue D, Matsunaga K, et al: Goniodomin A, an antifungal polyether macrolide, exhibits antiangiogenic activities via inhibition of actin reorganization in endothelial cells. J Cell Physiol 190: 109-116, 2002.
19. Puhr M, Santer FR, Neuwirt H, Marcias G, Hobisch A and Culig Z: SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling. Endocr Relat Cancer 17: 525-538, 2010.
20. Leelawat K, Leelawat S, Narong S and Hongeng S: Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion. World J Gastroenterol 13: 1561-1568, 2007.
21. Leelawat K, Leelawat S, Tepaksorn P, et al: Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met. J Surg Res 136: 78-84, 2006.